![]() | |
Clinical data | |
---|---|
Other names | MRZ-8456 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C17H15BrN4O |
Molar mass | 371.238 g·mol−1 |
3D model (JSmol) | |
| |
|
Remeglurant (INNTooltip International Nonproprietary Name; developmental code nameMRZ-8456) is adrug which acts as aselectiveantagonist of themGlu5 receptor.[1][2][3] It is under development by Merz Pharmaceuticals for the treatment ofdrug-induced dyskinesia but no development has been reported since at least 2016.[3]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |